The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 27, 2006

Filed:

Nov. 21, 2003
Applicants:

Mohammad R. Marzabadi, Ridgewood, NJ (US);

John Wetzel, Fairlawn, NJ (US);

John E. Deleon, North Bergen, NJ (US);

Yu Jiang, Jersey City, NJ (US);

Chien-an Chen, Flushing, NY (US);

Kai LU, Lake Hiawatha, NJ (US);

Inventors:

Mohammad R. Marzabadi, Ridgewood, NJ (US);

John Wetzel, Fairlawn, NJ (US);

John E. DeLeon, North Bergen, NJ (US);

Yu Jiang, Jersey City, NJ (US);

Chien-An Chen, Flushing, NY (US);

Kai Lu, Lake Hiawatha, NJ (US);

Assignee:

H. Lundbeck A/S, Valby-Copenhagen, DK;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/445 (2006.01); C07D 401/06 (2006.01);
U.S. Cl.
CPC ...
Abstract

This invention is directed to compounds which are selective antagonists for melanin concentrating hormone-1 (MCH1) receptors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier. This invention provides a pharmaceutical composition made by combining a therapeutically effective amount of the compound of this invention and a pharmaceutically acceptable carrier. This invention further provides a process for making a pharmaceutical composition comprising combining a therapeutically effective amount of the compound of the invention and a pharmaceutically acceptable carrier.


Find Patent Forward Citations

Loading…